^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    C-TCR055

    i
    Associations
    News

    Trials

    Company:
    AbelZeta Pharma
    Drug class:
    T lymphocyte replacement
    Related drugs:
    Associations
    News

    Trials

    Apply
    AFP Specific T Cell Receptor Transduced T Cells Injection(C-TCR055) in Unresectable Hepatocellular Carcinoma (NCT04368182)
    Phase 1
    Zhejiang University
    Unknown status
    Last update posted :
    04/29/2020
    Initiation :
    04/13/2020
    Primary completion :
    08/31/2020
    Completion :
    11/30/2021
    HLA-A • AFP
    |
    HLA-A*02 • AFP expression
    |
    C-TCR055
    AFP Specific T Cell Receptor Transduced T Cells Injection(C-TCR055) in Unresectable Hepatocellular Carcinoma (NCT03971747)
    Phase 1
    Cellular Biomedicine Group Ltd.
    Unknown status
    Last update posted :
    04/07/2020
    Initiation :
    08/06/2019
    Primary completion :
    06/01/2020
    Completion :
    04/01/2021
    HLA-A • AFP
    |
    HLA-A*02 • AFP expression
    |
    C-TCR055